Equifax Inc. (EFX) has long been a cornerstone of the credit reporting industry, but its story is one of resilience amid scandal and steady reinvention. The 2017 data breach, exposing sensitive information of 147 million Americans, cast a long shadow, triggering regulatory scrutiny, massive settlements, and a profitability plunge that echoed through 2018 and 2019. Yet, from those depths, Equifax clawed back with robust revenue expansion driven by workforce analytics, digital identity solutions, and non-mortgage growth—segments less tied to volatile housing cycles. Today, as we dissect the fundamentals through 2024 with analyst projections to 2027, the narrative points to a maturing giant leveraging data moats in an AI-fueled era, though insider selling and moderating margins warrant caution.
Revenue Momentum and Operational Scale
Revenue has been the bedrock of Equifax’s rebound, climbing from $3.14 billion in 2016 to $5.68 billion in 2024—a compound annual growth rate (CAGR) of about 7.7%. This trajectory accelerated post-pandemic, surging 81% from $4.13 billion in 2020 to $7.49 billion cumulative by 2024, fueled by a 20% employee headcount increase to 14,700 amid acquisitions and tech investments. Revenue per employee, a key productivity gauge, peaked at $388,000 in 2021 before settling at $386,000 in 2024, underscoring efficient scaling in high-margin verification services.
Looking ahead, analysts forecast continued acceleration: $6.07 billion in 2025 (7% growth), $6.73 billion in 2026 (11% up), and $7.39 billion in 2027 (10% more). This optimism correlates with rising revenue per share—from $26 in 2016 to a projected $61 by 2027—reflecting share stability around 120-123 million. In context, these figures signal Equifax’s pivot beyond traditional credit scores into employer services and alternative data, buffering against interest-rate sensitivity. Stock price highs mirrored this: soaring from $147 in 2017 to $300 in 2021, before a 2022 correction to $145 low amid macro headwinds, then rebounding to $310 high in 2024.
Profitability Recovery: Margins and Earnings Power
The breach’s scars were deepest in profitability. Earnings before taxes (EBT) cratered from $747 million in 2017 to a $414 million loss in 2019, dragging EBT margins to -11.8%—a critical red flag for operational health, as it highlighted remediation costs exceeding $1 billion. Net income followed suit, flipping to a $378 million loss. Recovery was swift: EBT rebounded to $810 million in 2024 (12% margin), with net income at $607 million, up 10% from 2023’s $552 million.
Key drivers include stabilizing gross margins around 55-56% since 2022 (down from 64% in 2016, reflecting pricing pressures and mix shift), bolstered by free cash flow per share jumping from $4.32 in 2020 to a projected $9.21 in 2025. Depreciation, rising 13% annually to $681 million in 2024, underscores heavy tech capex—$512 million last year, or 9% of revenue—to modernize platforms post-breach. ROE, a shareholder value litmus test, averaged 16% over the decade, peaking at 21.9% in 2021 before settling at 12.9% in 2024, still outperforming peers in a capital-intensive sector.
Earnings per share (EPS) tells a volatile but upward tale: from $4.89 in 2017 to a dismal -$3.30 in 2019, then climbing to $4.88 in 2024, with forecasts of $7.02 in 2026 (44% jump) and $8.63 in 2027 (23% more). This EPS growth outpaced revenue in projections, hinting at margin expansion via cost discipline. Stock prices tracked closely: PE ratios ballooned to 54x in 2023 during uncertainty, now at a more reasonable 41x forward, down from 48x in 2021 highs.
Balance Sheet Strength Amid Debt Discipline
Equifax’s balance sheet reflects prudent deleveraging. Total debt peaked at $5.79 billion in 2022 (post-acquisition binge) before shedding 25% to $4.32 billion in 2024—a $1.47 billion reduction that eased net debt to $4.15 billion. Shareholder equity swelled 77% since 2016 to $4.81 billion, lifting book value per share 70% to $38.89. This fortifies ROIC at 7.3% in 2024, up from negative territory post-breach, signaling better capital allocation.
Free cash flow (FCF) generation is a standout: $813 million in 2024 (14% of revenue), versus $133 million in 2022’s trough. Operating cash flow hit $1.32 billion, funding $512 million capex (down 15% YoY) while supporting dividends and buybacks. Working capital swings—negative $451 million in 2024—flag inventory-light operations but potential cash tie-ups in growth initiatives. EV/FCF multiples compressed from 225x in 2022 to 45x in 2024, aligning valuation with cash prowess. Stock lows in 2022 (145) bottomed as debt fears peaked, but highs recovered as deleveraging shone through.
Valuation Metrics: Reasonable but Stretched
At current levels, Equifax trades at a PS ratio of around 5.6x trailing sales, in line with historical averages (4-8x range), and a forward EV/Sales of 4-5x through 2026 projections. PB ratio hovers at 6.5x, premium to book but justified by 14% ROE. Compared to 2019’s distressed 4.8x PS amid losses, today’s metrics reflect premium for data network effects—hard to replicate post-breach trust rebuild.
Yet, correlations raise flags: insider selling dominates, with zero buys across 2025-early 2026. The CEO offloaded 140,000+ shares worth tens of millions (e.g., 48,264 shares in July 2025 at peak pricing, 49,345 in October), joined by EVP/CFO/COO (11,500 shares) and EVP/CTO (12,305 shares). Total sell proceeds near $41 million, no offsetting buys—a potential sentiment damper, though routine for vested executives. This contrasts bullish analyst forecasts, suggesting confidence in personal diversification over company doubts.
Stock Price Evolution and Analyst Sentiment
Equifax’s share price journey mirrors fundamentals: pre-breach highs of $147 (2017), post-breach lows sub-$90 (2018), pandemic surge to $300 (2021) on revenue boom, 2022 pullback to $146 amid rate hikes and slowdowns, then grinding higher—2024 low $213, high $310; 2025 low near recent troughs, high $281. The February 2026 close sits about even with recent lows, down from 2025 peaks.
Analyst price targets paint an upbeat picture: the mean implies roughly 24% upside from here, with high-end at 37% potential and low-end just 1% above. This consensus bets on EPS acceleration and FCF compounding, pricing in 10%+ revenue CAGR. Historically, when fundamentals aligned (e.g., 2021), the stock doubled lows; missteps like 2019 halved it. Current positioning—post-debt cuts, AI tailwinds—favors the former.
Future Outlook: Growth with Guardrails
Equifax’s narrative arcs toward $8+ EPS by 2027, with revenue per share at $61 and FCF/share over $9, potentially dropping PE to 22x—enticing for a 55% gross margin business. Tailwinds include regulatory tailwinds post-breach (e.g., enhanced cybersecurity mandates boosting demand) and macro recovery in lending. Risks? Insider sales signal caution; gross margins edging down (56.5% projected 2025) from competition; debt at $4.05 billion still looms if rates stay elevated.
In sum, Equifax isn’t flashy like fintech disruptors, but its moaty data empire—reforged in breach fires—positions it for 10-15% annual returns if execution holds. Buy on dips near recent lows, with 20-30% upside baked in by analysts. The storyteller’s bet: a chapter of steady compounding ahead, barring new plot twists.
(Word count: 1,128)